Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Innovestor is a Finnish investment manager founded in 2014, based in Helsinki. The firm specializes in venture capital, real estate, and energy storage, managing one of the largest private venture portfolios in the Nordics. Innovestor focuses on early-stage technology and life sciences, particularly in drug development and digital health, while also investing in energy-efficient commercial properties. The firm has developed a strong community that connects entrepreneurs, investors, and partners, facilitating collaboration and growth.
As of now, Innovestor manages over €250 million in assets across four venture capital funds, alongside its real estate arm. The firm has made significant strides in the Nordic and Baltic regions, with a portfolio that includes approximately 100 companies. Innovestor's commitment to impactful investments is evident in its focus on businesses that not only generate financial returns but also create significant societal benefits.
Innovestor's office is located at Annankatu 12, 00120 Helsinki, Finland. The firm has established a reputation for its active involvement in the startup ecosystem, providing corporate venturing services that connect corporates with the European startup market.
Innovestor primarily invests in early-stage technology and life science startups, with a strong emphasis on drug development and digital health solutions. The firm targets pre-seed, seed, and seed-plus stages, making investments in sectors such as AI, healthcare, biotech, fintech, consumer products, energy, climate, SaaS, industrial, and proptech. Innovestor's check sizes typically range from €100,000 to €2 million, depending on the stage and specific needs of the startup.
In addition to its venture capital investments, Innovestor also focuses on cash-flow generating, energy-efficient commercial properties and integrated battery storage solutions. The firm provides corporate venturing services, which help corporates access the European startup market and establish effective partnerships with innovative startups. Innovestor seeks founders who demonstrate strong leadership, a clear vision, and the ability to execute their business plans effectively.
Innovestor's portfolio is diverse, featuring approximately 100 companies across various sectors. Notable companies include:
These companies reflect Innovestor's commitment to investing in impactful technologies and solutions that address pressing challenges in healthcare, energy, and digital transformation.
Wilhelm Lindholm: Group CEO with extensive experience in venture capital and investment management.
Tommi Äijälä: Group Chair, providing strategic oversight and leadership.
Tomi Asanti: Managing Partner, Real Estate, specializing in energy-efficient commercial properties.
Matti Härkönen: Partner, Corporate Venturing, focusing on startup-corporate collaborations.
Heli Mehtätalo-Takala: Head of Investor Relations & Communications, responsible for managing investor relationships.
Aleksi Huhta: Director, Investor Relations, facilitating communication with investors.
Mikko Rautiainen: Investment Manager, Innovestor Venture Capital, involved in evaluating potential investments.
Linda Hasi: Finance & Operations Manager, overseeing financial operations.
Essi Hänninen: Office Manager, ensuring smooth office operations.
Greete Pöder: Legal Counsel, providing legal support for investments.
Piia Maaranen: Partner, Innovestor Venture Capital, with expertise in early-stage investments.
Janne Juhola: Partner, Innovestor Venture Capital, focusing on technology investments.
Hannu Jungman: Partner, Innovestor Venture Capital, specializing in healthcare investments.
Petri Laine: Partner, Innovestor Venture Capital, with a background in fintech.
Myron Seto: Partner, Innovestor Venture Capital, focusing on SaaS investments.
Lauri Karjalainen: Investment Manager, Innovestor Venture Capital, involved in deal sourcing.
Pekka Simula: Partner, Innovestor Life Science, specializing in biotech investments.
Milla Koistinaho: Partner, Innovestor Life Science, focusing on digital health.
Marko Kuisma: Partner, Innovestor Life Science, with expertise in drug development.
Sara Kangaspeska: Investment Director, Innovestor Life Science, involved in portfolio management.
Elie Kopaly: Investment Director, Energy Storage, focusing on energy-efficient solutions.
Toni Turpeenniemi: Asset Manager, Real Estate, managing real estate investments.
Otto Silvennoinen: Junior Asset Manager, Real Estate, supporting asset management activities.
Henrik Keinonen: Director, Investor Relations, enhancing investor engagement.
Leo Pohjala: Asset Manager, Real Estate, overseeing property investments.
Susanna Lyytikäinen: Analyst, Energy Storage, conducting market research.
Veeti Vuorenhela: Junior Asset Manager, Real Estate, assisting in asset management.
Paavo Grönqvist: Trainee, Real Estate, gaining experience in the field.
Teemu Pakarinen: Trainee, Investor Relations, supporting investor communications.
Emilia Carlqvist: Analyst, Innovestor Life Science, involved in investment analysis.
Founders interested in pitching to Innovestor should submit their proposals through the firm's website at innovestorgroup.com. It is advisable to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and financial projections. Innovestor prefers well-structured presentations that clearly convey the startup's vision and potential for growth.
Response times can vary, but founders can expect to hear back within a few weeks. Innovestor values warm introductions, so leveraging connections within their network can enhance the chances of a successful pitch.
In 2024, Innovestor led a SEK 304 million Series B investment in Gesynta Pharma, a Swedish company developing a drug candidate for endometriosis. This round included co-investors such as Hadean Ventures and Industrifonden.
Additionally, Innovestor participated in a Series B round for HVR Cardio, a Finnish medical device company focused on cardiovascular solutions. The firm continues to expand its portfolio with investments in Polku Therapeutics and Neumirna Therapeutics, both in the life sciences sector.
Innovestor has also announced plans for 2025, targeting 74 new investments and highlighting a recent exit in real estate involving integrated battery systems. The firm is collaborating with Grid.vc to develop the next generation of funds, further enhancing its investment capabilities.
What are Innovestor's investment criteria?
Innovestor focuses on early-stage technology and life science startups, particularly in drug development and digital health. The firm invests in sectors such as AI, healthcare, biotech, fintech, consumer products, energy, climate, SaaS, industrial, and proptech.
How can I pitch Innovestor?
Founders can pitch Innovestor through their website at innovestorgroup.com. It is recommended to include a clear business plan, market analysis, and financial projections in the pitch deck.
What makes Innovestor different from other VCs?
Innovestor combines venture capital with corporate venturing services, facilitating connections between corporates and startups. This unique approach enhances deal flow and partnership opportunities for portfolio companies.
What is Innovestor's geographic focus?
The firm primarily invests in the Nordic and Baltic regions, with a strong emphasis on the Finnish market.
What is the typical check size for investments?
Innovestor typically invests between €100,000 and €2 million, depending on the stage of the startup and its specific needs.
How involved is Innovestor post-investment?
Innovestor actively supports its portfolio companies through strategic guidance, access to a vast network of industry connections, and expertise in corporate venturing.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.